Roche and Temedica Pilot Digital Companion for MS Patients

Germany’s Temedica and Swiss pharma giant Roche have teamed up to develop a new mobile app companion for multiple sclerosis patients. The device is designed to deepen understanding of the disease based on real-world data gained from MS patients.